BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2739340)

  • 1. [The clinical significance of pseudouridine determination of the urine in children and adolescents].
    Graf N; Bach K; Frisch B; Haas HJ; Sitzmann FC
    Klin Padiatr; 1989; 201(3):154-62. PubMed ID: 2739340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of pseudouridine and creatinine in urine of normal children and patients with leukaemia by high performance liquid chromatography.
    Li Y; Wang S; Zhong N
    Biomed Chromatogr; 1992; 6(4):191-3. PubMed ID: 1643387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excretion patterns of pseudouridine and beta-aminoisobutyric acid in patients with tumours of the upper urinary tract.
    Kvist E; Sjølin KE; Iversen J
    Scand J Urol Nephrol; 1990; 24(4):287-92. PubMed ID: 2274753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudouridine and beta-aminoisobutyric acid excretion in urine: diagnostic and prognostic value.
    Kvist E; Sjølin KE
    Scand J Urol Nephrol; 1990; 24(4):283-5. PubMed ID: 2274752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary pseudouridine as a biochemical marker in the diagnosis and monitoring of primary hepatocellular carcinoma.
    Tamura S; Fujioka H; Nakano T; Amuro Y; Hada T; Nakao N; Higashino K
    Am J Gastroenterol; 1988 Aug; 83(8):841-5. PubMed ID: 2456010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudouridine: a modified nucleoside as biological marker in malignant lymphomas.
    Rasmuson T; Björk GR
    Cancer Detect Prev; 1983; 6(1-2):293-6. PubMed ID: 6883387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of receiver operating characteristic (ROC) curves analysis in the evaluation of the diagnostic efficiency of serum pseudouridine as a tumor marker.
    Savoia M; Pane F; Fortunato G; Salvatore F; Sacchetti L
    Ital J Biochem; 1988; 37(2):119-27. PubMed ID: 3403212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of elevated amounts of urinary pseudouridine in cancer patients by use of a monoclonal antibody.
    Itoh K; Mizugaki M; Ishida N
    Clin Chim Acta; 1989 May; 181(3):305-15. PubMed ID: 2758683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of urinary and serum pseudouridine in diagnosis and monitoring of primary liver cancer.
    Tu Z; Xu S; Wu M
    Chin Med J (Engl); 1995 Mar; 108(3):204-8. PubMed ID: 7796629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudouridine: a prognostic marker in non-Hodgkin's lymphomas.
    Rasmuson T; Björk GR
    Cancer Detect Prev; 1985; 8(1-2):287-90. PubMed ID: 4064048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of pseudouridine and creatinine in untreated urine by ion-pair liquid chromatography with diode-array ultraviolet detection.
    Palmisano F; Rotunno T; Guerrieri A; Zambonin PG
    J Chromatogr; 1989 Aug; 493(1):35-43. PubMed ID: 2778020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of urinary neopterin and pseudouridine in patients with malignant proliferative diseases.
    Motyl T; Traczyk Z; Holska W; Daniewska-Michalska D; Cieśluk S; Kukulska W; Kałuzny Z; Podgurniak M
    Eur J Clin Chem Clin Biochem; 1993 Apr; 31(4):205-9. PubMed ID: 8318566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of urinary excretion of modified nucleosides to disease status in childhood acute lymphoblastic leukemia.
    Heldman DA; Grever MR; Miser JS; Trewyn RW
    J Natl Cancer Inst; 1983 Aug; 71(2):269-73. PubMed ID: 6576186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the advantage of determination of urinary pseudouridine for the early detection of a malignant transformation process].
    Senden D; Buchet JP; Lauwerys R
    J Toxicol Clin Exp; 1990; 10(7-8):473-80. PubMed ID: 2135063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudouridine determination in blood serum as tumor marker.
    Salvatore F; Russo T; Colonna A; Cimino L; Mazzacca G; Cimino F
    Cancer Detect Prev; 1983; 6(6):531-6. PubMed ID: 6318996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary pseudouridine/creatinine ratio as an indicator of gastrointestinal cancer.
    Higley B; De Mello J; Oakes DJ; Giles GR
    Br J Surg; 1982 Dec; 69(12):699-701. PubMed ID: 7171969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Excretion of normal and modified RNA catabolites and creatinine in the urine as a function of nutrition in children].
    Schöch G; Heller-Schöch G; Müller J; Clemens P; Holtgrewe A; Heddrich M
    Monatsschr Kinderheilkd; 1983 May; 131(5):259-63. PubMed ID: 6192333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pseudouridine and uric acid excretion in patients with viral hepatitis].
    Lifshits RI; Salomatin VV; Efimenko GP
    Vopr Med Khim; 1976; 22(5):687-90. PubMed ID: 1014482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the age dependency of the creatinine-related pseudouridine excretion in children's urine by high-performance liquid chromatography.
    Assmann B; Haas HJ
    J Chromatogr; 1988 Dec; 434(1):202-8. PubMed ID: 3243814
    [No Abstract]   [Full Text] [Related]  

  • 20. Pseudouridine excretion in patients with psoriasis.
    Clemmensen OJ; Kieffer M; Sjølin KE
    Acta Derm Venereol; 1987; 67(4):310-4. PubMed ID: 2445149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.